MedPath

NOMAC : New Tools for Managing the Fate of Cereal Nutrients in the Gut : Effects of Amylose Content on Glycemic Index.

Not Applicable
Completed
Conditions
Healthy
Interventions
Other: 20% amylose bread
Dietary Supplement: 10% amylose bread
Dietary Supplement: Carbohydrates
Registration Number
NCT01437917
Lead Sponsor
Rennes University Hospital
Brief Summary

The consumption of cereals-based foods with low glycemic indexes, high micronutrients and fibers contents are highly recommended. The target of this work is to provide new solutions for cereal based foods: the knowledge and understanding on the in vivo fate will be used to define structural features to gain in foods.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Healthy individual,
  • Age between 19-65 years
  • With normal food habits with at least 2 main meals per day
  • Non smoking
  • Having filled the consent form
Exclusion Criteria
  • BMI > 25 kg/m2,
  • Diabetes or any illness susceptible to alter
  • Coeliac disease
  • Past history of intestinal diseases.
  • Treatment susceptible of modifying glycemia.
  • Allergy

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Bread with 20% amylose content20% amylose breadBread with 20% amylose content
Bread with 10% amylose content10% amylose breadBread with 10% amylose content
carbohydratesCarbohydrates50g of carbohydrates ingested with 400 ml of water
Primary Outcome Measures
NameTimeMethod
Glycemic index for each bread2 hours

To compare the glycemic index of breads made with different amylose content. (S1 to S6) A total of 6 visits. In each visit, blood samples will be taken for measurement of glycemia and insulinemia over 2 hours after ingestion of 50 of carbohydrates ingested with 400 ml of water.

Secondary Outcome Measures
NameTimeMethod
AUC for insulinemia for the 2 hours following the ingestion of each bread.2 hours

To compare the AUC for insulinemia for the 2 hours following the ingestion of each bread.

Trial Locations

Locations (1)

Rennes University Hospital

🇫🇷

Rennes, Bretagne, France

© Copyright 2025. All Rights Reserved by MedPath